3Witowski J,Kawka E,Rudolf A,et al.New developments in peritoneal fibroblast biology:implications for inflammation and fibrosis in peritoneal dialysis[J].Biomed Res Int,2015,2015:134708. 被引量：1
4Saxena AB.Recent advances in the management of peritoneal dialysis patients[J].F1000prime reports,2015,7:57. 被引量：1
5Qu ZS,Zhang QD,Li L.Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress,nitric oxide and endothelin in cerebral infarction complicated with uremia[J].Int J Clin Exp Med,2015,8(1):1333-1341. 被引量：1
6Honda K,Hamada C,Nakayama M,et al.Impact of uremia,diabetes,and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis:a quantitative study of peritoneal membrane morphology[J].Clin J Am Soc Nephrol,2008,3(3):720-728. 被引量：1
7Wang J,Liu S,Li H,et al.A review of rodent models of peritoneal dialysis and its complications[J].Int Urol Nephrol,2015,47(1):209-215. 被引量：1
8Meyer TW,Hostetter TH.Approaches to uremia[J].J Am Soc Nephrol,2014,25(10):2151-2158. 被引量：1
9Rhee EP,Thadhani R.New insights into uremia-induced alterations in metabolic pathways[J].Curr Opin Nephrol Hypertens,2011,20(6):593-598. 被引量：1
10Wanner C,Drechsler C,Krane V.C-reactive protein and uremia[J].Semin Dial,2009,22(4):438-441. 被引量：1
